NCT03597217View on ClinicalTrials.gov

A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 27, 2018

Primary Completion Date

November 15, 2018

Study Completion Date

November 15, 2018

Conditions
Healthy
Interventions
DRUG

PF-05221304

3, 10, 50 mg

DRUG

PF-05221304

50 mg multiple dose

DRUG

Placebo

Placebo

Trial Locations (1)

192-0071

P-one Clinic, Keikokai Medical Corporation, Hachioji-shi

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03597217 - A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults | Biotech Hunter | Biotech Hunter